ABSTRACT
Through The Milestone Bridge the author compares the business models of firms. The business model in the first years was focused on R&D and Product Development. Areta International was founded by Maria Luisa Nolli in autumn 1999 as a spin-off of Cell Biology and Immunology Laboratories of Lepetit Research Center, part of multinational group of Dow Pharma. Areta was founded as a research and development company for biotechnological products, leveraging its experience gained in the generation of monoclonal and polyclonal antibodies and ELISA. Neurosilicon is a life science company advancing healthcare-related research through enabling rapid, non-invasive, targeted excitation of excitable cells. Napo Pharmaceuticals Inc. is venture-backed company based in South San Francisco that focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace in collaboration with local partners. TK is a personalized therapy that makes possible marrow transplants to patients who do not have a fully compatible donor.
